GFAP and dementia: A recent study found higher levels of biomarkers of cerebral injury such as microtubule-associated Tau protein and glial fibrillary acidic protein (GFAP) in AF patients, suggesting potential blood–brain barrier (BBB, the protective physiological barrier of the brain) disruption, which could lead to cognitive decline or dementia in future [22].